HSBC Holdings’s Fate Therapeutics FATE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $118K | Sell |
102,966
-6,380
| -6% | -$7.31K | ﹤0.01% | 2346 |
|
|
2025
Q1 | $83.5K | Sell |
109,346
-76
| -0.1% | -$58 | ﹤0.01% | 2392 |
|
|
2024
Q4 | $179K | Buy |
109,422
+19,706
| +22% | +$32.2K | ﹤0.01% | 2330 |
|
|
2024
Q3 | $320K | Buy |
89,716
+1,202
| +1% | +$4.29K | ﹤0.01% | 1929 |
|
|
2024
Q2 | $283K | Buy |
88,514
+22,583
| +34% | +$72.3K | ﹤0.01% | 1971 |
|
|
2024
Q1 | $484K | Sell |
65,931
-12,816
| -16% | -$94.1K | ﹤0.01% | 1741 |
|
|
2023
Q4 | $295K | Sell |
78,747
-31,645
| -29% | -$119K | ﹤0.01% | 1841 |
|
|
2023
Q3 | $237K | Buy |
110,392
+75,039
| +212% | +$161K | ﹤0.01% | 1848 |
|
|
2023
Q2 | $169K | Sell |
35,353
-7,055
| -17% | -$33.7K | ﹤0.01% | 1934 |
|
|
2023
Q1 | $240K | Sell |
42,408
-1,390
| -3% | -$7.87K | ﹤0.01% | 1897 |
|
|
2022
Q4 | $438K | Buy |
43,798
+18,701
| +75% | +$187K | ﹤0.01% | 1903 |
|
|
2022
Q3 | $578K | Buy |
25,097
+14,623
| +140% | +$337K | ﹤0.01% | 1702 |
|
|
2022
Q2 | $258K | Buy |
10,474
+2,133
| +26% | +$52.5K | ﹤0.01% | 2310 |
|
|
2022
Q1 | $331K | Buy |
+8,341
| New | +$331K | ﹤0.01% | 2330 |
|
|
2021
Q3 | – | Sell |
-4,223
| Closed | -$368K | – | 2542 |
|
|
2021
Q2 | $368K | Buy |
+4,223
| New | +$368K | ﹤0.01% | 1974 |
|
|
2020
Q4 | – | Sell |
-12,391
| Closed | -$502K | – | 2581 |
|
|
2020
Q3 | $502K | Sell |
12,391
-3,461
| -22% | -$140K | ﹤0.01% | 1555 |
|
|
2020
Q2 | $544K | Buy |
15,852
+5,573
| +54% | +$191K | ﹤0.01% | 1443 |
|
|
2020
Q1 | $233K | Buy |
+10,279
| New | +$233K | ﹤0.01% | 1793 |
|